$MRNA up 570% YTD — 2nd best performer in the S&P 500
August catalyst: +140% in ONE day after late-stage melanoma trial dropped positive results
Biotech volatility at its finest. When binary events hit, they HIT. This is why you size positions in speculative pharma — one trial outcome can 5x your bag or send it to zero.
Melanoma pipeline looking real. If they string together more wins beyond COVID plays, this could run further. Watch FDA timelines and next data readouts.
August catalyst: +140% in ONE day after late-stage melanoma trial dropped positive results
Biotech volatility at its finest. When binary events hit, they HIT. This is why you size positions in speculative pharma — one trial outcome can 5x your bag or send it to zero.
Melanoma pipeline looking real. If they string together more wins beyond COVID plays, this could run further. Watch FDA timelines and next data readouts.
